Name (Synonyms) | Correlation | |
---|---|---|
drug2578 | Two doses of placebo at the schedule of day 0,28 Wiki | 1.00 |
drug2572 | Two doses of low dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 Wiki | 1.00 |
drug2571 | Two doses of high dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 Wiki | 1.00 |
drug2575 | Two doses of medium dosage inactivated SARS-CoV-2 vaccine at the schedule of day 0,28 Wiki | 1.00 |
Name (Synonyms) | Correlation | |
---|---|---|
D015212 | Inflammatory Bowel Diseases NIH | 0.50 |
D045169 | Severe Acute Respiratory Syndrome NIH | 0.05 |
D018352 | Coronavirus Infections NIH | 0.04 |
Name (Synonyms) | Correlation | |
---|---|---|
HP:0002242 | Abnormal intestine morphology HPO | 1.00 |
HP:0002037 | Inflammation of the large intestine HPO | 0.50 |
There is one clinical trial.
To find out what adaptations have been made by Inflammatory bowel disease physicians and patients in relation to therapies in flaring IBD patients during severe acute respiratory syndrome 2-COV and what the impact of these is on IBD patients with no symptomatic COVID-19 and in suspected/confirmed COVID-19. Also whether there any IBD related factors impacting the outcome of patients with COVID-19 symptoms or COVID-19 disease